Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

562
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
562
Principal Stresses in a Beam01:11

Principal Stresses in a Beam

714
In prismatic beams subject to arbitrary transverse loading, It is essential to analyze the interaction between shear forces and bending moments in order to understand stress distribution and ensure structural integrity. The highest normal or bending stress occurs at the outer fibers of the beam, decreasing linearly to zero at the neutral axis. In contrast, shear stress peaks at the neutral axis and diminishes toward the outer surfaces.
Analyzing principal stresses is crucial, especially in...
714
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

529
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
529
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

326
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
326
Principal Stresses01:24

Principal Stresses

818
The graphical depiction of normal and shearing stress equations is represented by a circle, demonstrating the interplay between these stresses under different angular conditions. The center of this circle C, located on the vertical axis, represents the average normal stress, while its radius shows the range of stress variations. At points A and B, where the circle intersects the horizontal axis, the maximum and minimum normal stresses are observed, occurring without shearing stress. These...
818
Principal Moments of Area01:14

Principal Moments of Area

1.7K
In mechanics, the product of inertia and moments of inertia of area help to calculate the stability and performance of various structures and components. The coordinate transformation relations are used to calculate the moments and products of inertia for an area about the inclined axes. Further, the moments and products of inertia with respect to the principal axes can be determined using the moments and products of inertia about the inclined axes.
The principal moment of inertia axes are the...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SpatioTemporal Omics Consortium: a global effort for biological discovery across species, space and time.

Nature methods·2026
Same author

APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analyses.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Genetic Investigation of Corrected QT Interval Sensitivity to Oral Bepridil Hydrochloride Hydrate in Patients With Atrial Fibrillation.

Journal of the American Heart Association·2026
Same author

Microarray-Based Identification of Time-Sensitive miRNAs as Serum Quality Indicators in Liquid Biopsy.

Genes to cells : devoted to molecular & cellular mechanisms·2026
Same author

Machine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population.

Circulation. Genomic and precision medicine·2026
Same author

Genetic Variants Associated With Nonpulmonary Vein Triggers of Atrial Fibrillation: A Genome-Wide Association Study.

JACC. Advances·2026

Related Experiment Video

Updated: Jan 28, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K

Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression

Daichi Shigemizu1,2,3,4, Shintaro Akiyama5, Yuya Asanomi5

  • 1Medical Genome Center, National Center for Geriatrics and Gerontology, Obu, Aichi, 474-8511, Japan. daichi@ncgg.go.jp.

Communications Biology
|March 2, 2019
PubMed
Summary
This summary is machine-generated.

This study identifies microRNAs (miRNAs) as novel biomarkers for dementia subtypes like Alzheimer's disease (AD), Vascular Dementia (VaD), and Dementia with Lewy Bodies (DLB). miRNA-based models accurately predict dementia risk in a prospective cohort, showing potential for clinical application.

More Related Videos

Use of Principal Components for Scaling Up Topographic Models to Map Soil Redistribution and Soil Organic Carbon
09:44

Use of Principal Components for Scaling Up Topographic Models to Map Soil Redistribution and Soil Organic Carbon

Published on: October 16, 2018

10.7K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K

Related Experiment Videos

Last Updated: Jan 28, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K
Use of Principal Components for Scaling Up Topographic Models to Map Soil Redistribution and Soil Organic Carbon
09:44

Use of Principal Components for Scaling Up Topographic Models to Map Soil Redistribution and Soil Organic Carbon

Published on: October 16, 2018

10.7K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K

Area of Science:

  • Biomarkers and Diagnostics
  • Neuroscience
  • Genetics and Genomics

Background:

  • Dementia, including Alzheimer's disease (AD), Vascular Dementia (VaD), and Dementia with Lewy Bodies (DLB), poses a significant health challenge.
  • MicroRNAs (miRNAs) are emerging as promising novel biomarkers for various diseases, including dementia.
  • Accurate and early diagnosis of dementia subtypes is crucial for effective management and treatment.

Purpose of the Study:

  • To investigate serum miRNA expression profiles for identifying novel dementia biomarkers.
  • To construct and validate subtype-specific miRNA-based risk prediction models for dementia.
  • To assess the potential clinical utility of miRNA biomarkers in prospective dementia risk prediction.

Main Methods:

  • Serum samples from 1,601 Japanese individuals were analyzed for miRNA expression.
  • Supervised principal component analysis (PCA) logistic regression was employed to build risk prediction models.
  • Models were validated on a separate cohort to assess predictive accuracy for AD, VaD, and DLB.

Main Results:

  • Risk prediction models demonstrated high accuracy: 0.873 for AD (78 miRNAs), 0.836 for VaD (86 miRNAs), and 0.825 for DLB (110 miRNAs).
  • This study represents the first application of miRNA-based risk prediction models in a dementia prospective cohort.
  • The developed models showed effectiveness in prospective disease risk prediction.

Conclusions:

  • Serum miRNAs can serve as effective biomarkers for predicting the risk of dementia subtypes.
  • The developed miRNA-based risk prediction models show promise for future clinical application in dementia diagnosis.
  • Further refinement of these models could significantly contribute to early and accurate dementia detection.